Coya Therapeutics, Inc.
Price Action
Technical Summary
CONSOLIDATINGCoya Therapeutics, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 67), indicating performance broadly in line with the market. Earnings growth of 27% provides fundamental context to the price action. However, price is extended 29% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.94 | +22.94% | ABOVE |
| 50 SMA | $4.69 | +29.46% | ABOVE |
| 100 SMA | $4.61 | +31.57% | ABOVE |
| 150 SMA | $4.88 | +24.49% | ABOVE |
| 200 SMA | $5.17 | +17.38% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is COYA in an uptrend right now?
COYA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is COYA overbought or oversold?
COYA's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is COYA outperforming the market?
COYA has a Relative Strength (RS) Rating of 67 out of 99. COYA is performing about average compared to the market.
Where is COYA in its 52-week range?
COYA is trading at $6.07, which is 78% of its 52-week high ($7.75) and 58% above its 52-week low ($3.71).
How volatile is COYA?
COYA has a Beta of 1.25 and 52-week volatility of 65%. It's more volatile than the S&P 500 - expect bigger swings.